145 related articles for article (PubMed ID: 20674388)
1. Expression, refolding and purification of a human interleukin-17A variant.
Wu B; Nemeth JF; Janecki DJ; Jones B; Obmolova G; Malia TJ; Baker A; Bethea D; Elloso MM; Naso M; Taudte S
Cytokine; 2011 Jan; 53(1):107-14. PubMed ID: 20674388
[TBL] [Abstract][Full Text] [Related]
2. The role of interchain disulfide bond in a recombinant human interleukin-17A variant.
Wu B; Muzammil S; Jones B; Nemeth JF; Janecki DJ; Baker A; Merle Elloso M; Naso M; Carton J; Taudte S
Cytokine; 2014 Feb; 65(2):167-74. PubMed ID: 24345576
[TBL] [Abstract][Full Text] [Related]
3. Production and purification of refolded recombinant Plasmodium falciparum beta-ketoacyl-ACP reductase from inclusion bodies.
Karmodiya K; Srivastav RK; Surolia N
Protein Expr Purif; 2005 Jul; 42(1):131-6. PubMed ID: 15939298
[TBL] [Abstract][Full Text] [Related]
4. A high-throughput protein refolding screen in 96-well format combined with design of experiments to optimize the refolding conditions.
Dechavanne V; Barrillat N; Borlat F; Hermant A; Magnenat L; Paquet M; Antonsson B; Chevalet L
Protein Expr Purif; 2011 Feb; 75(2):192-203. PubMed ID: 20851186
[TBL] [Abstract][Full Text] [Related]
5. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Lin Z; Lei H; Cao P
Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
[TBL] [Abstract][Full Text] [Related]
6. Production and purification of refolded recombinant human IL-7 from inclusion bodies.
Ouellette T; Destrau S; Ouellette T; Zhu J; Roach JM; Coffman JD; Hecht T; Lynch JE; Giardina SL
Protein Expr Purif; 2003 Aug; 30(2):156-66. PubMed ID: 12880763
[TBL] [Abstract][Full Text] [Related]
7. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
8. Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2.
Esfandiar S; Hashemi-Najafabadi S; Shojaosadati SA; Sarrafzadeh SA; Pourpak Z
Biotechnol Appl Biochem; 2010 Apr; 55(4):209-14. PubMed ID: 20236092
[TBL] [Abstract][Full Text] [Related]
9. On-column refolding and purification of transglutaminase from Streptomyces fradiae expressed as inclusion bodies in Escherichia coli.
Liu XQ; Yang XQ; Xie FH; Song LY; Zhang GQ; Qian SJ
Protein Expr Purif; 2007 Feb; 51(2):179-86. PubMed ID: 16935525
[TBL] [Abstract][Full Text] [Related]
10. Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli.
Bu D; Zhou Y; Tang J; Jing F; Zhang W
Protein Expr Purif; 2013 Dec; 92(2):203-7. PubMed ID: 24128692
[TBL] [Abstract][Full Text] [Related]
11. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
12. [Influence of the reductase deficient Escherichia coli on the solubility of recombinant proteins produced in it].
Xiong S; Zhang MY; Qian CW; Ran YC; Wang YF; Ren XR; Su KY; Yu ZY
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):686-91. PubMed ID: 15971580
[TBL] [Abstract][Full Text] [Related]
13. Rat interleukin 6: expression in recombinant Escherichia coli, purification and development of a novel ELISA.
Rees GS; Ball C; Ward HL; Gee CK; Tarrant G; Mistry Y; Poole S; Bristow AF
Cytokine; 1999 Feb; 11(2):95-103. PubMed ID: 10089129
[TBL] [Abstract][Full Text] [Related]
14. Purification and refolding of recombinant human interferon-gamma in urea-ammonium chloride solution.
Petrov S; Nacheva G; Ivanov I
Protein Expr Purif; 2010 Sep; 73(1):70-3. PubMed ID: 20363329
[TBL] [Abstract][Full Text] [Related]
15. Purification of a bioactive recombinant human Reg IV expressed in Escherichia coli.
Hu G; Shen J; Cheng L; Xiang D; Zhang Z; He M; Lu H; Zhu S; Wu M; Yu Y; Wang X; Han W
Protein Expr Purif; 2010 Feb; 69(2):186-90. PubMed ID: 19699332
[TBL] [Abstract][Full Text] [Related]
16. Expression, purification and characterization of refolded rBm-33 (pepsin inhibitor homolog) from Brugia malayi: a human Lymphatic Filarial parasite.
Krishna NR; Krushna NS; Narayanan RB; Rajan SS; Gunasekaran K
Protein Expr Purif; 2011 Oct; 79(2):245-50. PubMed ID: 21745575
[TBL] [Abstract][Full Text] [Related]
17. Matrix-assisted refolding of oligomeric small heat-shock protein Hsp26.
Franzmann TM
Int J Biol Macromol; 2006 Aug; 39(1-3):104-10. PubMed ID: 16626802
[TBL] [Abstract][Full Text] [Related]
18. On-column refolding of recombinant human interleukin-4 from inclusion bodies.
Razeghifard MR
Protein Expr Purif; 2004 Sep; 37(1):180-6. PubMed ID: 15294296
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli.
Sharma K; Babu PV; Sasidhar P; Srinivas VK; Mohan VK; Krishna E
Protein Expr Purif; 2008 Jul; 60(1):7-14. PubMed ID: 18430585
[TBL] [Abstract][Full Text] [Related]
20. Expression, refolding, and activity of a recombinant nonhemorrhagic snake venom metalloprotease.
Selistre-de-Araujo HS; de Souza EL; Beltramini LM; Ownby CL; Souza DH
Protein Expr Purif; 2000 Jun; 19(1):41-7. PubMed ID: 10833388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
